Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App





Randox Promotes Evidence MultiSTAT Automated Benchtop Immunoassay Analyzer

By Theresa Herman, Regional Director
Posted on 31 Jan 2019
Randox Laboratories (Crumlin, UK) participated in MedLab Middle East 2019 held in Dubai, UAE, from February 4-7, 2019, where it offered live product demonstrations of the Evidence MultiSTAT automated benchtop immunoassay analyzer.

The Evidence MultiSTAT simultaneously detects up to 21 classical, prescription and synthetic drugs from a single patient sample. More...
Utilizing revolutionary Biochip Array Technology, it uses a chemiluminescence reaction as a measuring principle to ensure consistently accurate results. Moving away from traditional single analyte assays, Biochip Array Technology boasts of cutting-edge multiplex testing capabilities providing rapid and accurate drug detection from a single sample. Biochip Array Technology has a proven high standard of accurate test results with CVs typically <10% with a 98% agreement with confirmatory methods.

Based on ELISA principles, the biochip is a solid-state device with discrete test sites onto which antibodies specific to different drug compounds are immobilized and stabilized. Competitive chemiluminescent immunoassays are then employed, offering a highly sensitive screen. Testing panels are available for blood and urine samples to accommodate various testing requirements, with a minimal 200ul sample volume required, ensuring more sample is available for confirmatory testing.

Randox has the world’s largest toxicology test menu, with the ability to detect over 500 drugs and drug metabolites. Randox also has the world’s most advanced drug screening test menu spanning a wide range of classical, prescription and synthetic drugs of abuse. The Evidence Multistat provides a complete drug profile in one simple process, reducing the amount of time and labor spent on individual tests. The reliability and accuracy of results also reduces the financial burden of re-testing. With multiple results obtained in less than 20 minutes, the Evidence MultiSTAT is an ideal analyzer for emergency drugs of abuse screening.


Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Pan-Cancer Panel
TruSight Oncology 500
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.